Page last updated: 2024-10-30

ly 171883 and Chronic Disease

ly 171883 has been researched along with Chronic Disease in 1 studies

LY 171883: structure in first source; leukotriene receptor antagonist
tomelukast : A member of the class of acetophenones that is 1-phenylethanone substituted at position 2 by a hydroxy group, a propyl group at position 3 and a 4-(1H-tetrazol-5-yl)butoxy group at position 4. A leukotriene antagonist, it exhibits anti-asthmatic activity.

Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cloud, ML1
Enas, GC1
Kemp, J1
Platts-Mills, T1
Altman, LC1
Townley, R1
Tinkelman, D1
King, T1
Middleton, E1
Sheffer, AL1

Trials

1 trial available for ly 171883 and Chronic Disease

ArticleYear
A specific LTD4/LTE4-receptor antagonist improves pulmonary function in patients with mild, chronic asthma.
    The American review of respiratory disease, 1989, Volume: 140, Issue:5

    Topics: Acetophenones; Adolescent; Adult; Asthma; Chemical Phenomena; Chemistry; Chronic Disease; Female; Fo

1989